NEW YORK --(BUSINESS WIRE)--Nov. 22, 2017-- Piper Jaffray Companies (NYSE: PJC), a leading investment bank and asset management firm, will host its 29th annual Healthcare Conference in New York on November 28-29, 2017 .

The Piper Jaffray Healthcare Conference will showcase senior management teams from nearly 275 leading public and private companies delivering presentations to an audience of nearly 1,700, including institutional investors, equity portfolio managers and research analysts. The two-day event will also host more than 3,300 private one-on-one meetings with company management. Presenting companies represent several healthcare sectors, including: biotechnology, specialty pharmaceuticals, medical technology, medical diagnostics, healthcare technology and services.

Highlighting the conference will be several panel discussions featuring industry experts, physicians and academicians moderated by Piper Jaffray healthcare senior research analysts:

• Diabetes Panel
  Co-Moderated by Matt O’Brien and JP McKim, CFA

• M&A, Partnership & Investment in Pharma Panel
  Moderated by Matt Hemsley

• Health.ai: Opportunities and Challenges in the Application of Artificial Intelligence in Healthcare
  Moderated by Sean Wieland

• Emerging Treatment Options in Dermatology
  Moderated by David Amsellem

“As the healthcare industry is rapidly accelerating in innovation and technology, we strive to offer our clients an intimate experience with some of the industry’s key leaders,” said Michael Cox , director of equity research at Piper Jaffray . “Through company presentations, fireside chats, panel presentations and one-on-one meetings, the conference offers a variety of experiences for our clients to learn about and network with companies.”

Follow the conversation using the event hashtag #PJCHCC17

Company and investor participation in the conference is by invitation only. Clients interested in attending should contact their Piper Jaffray representative. General and research-related media inquiries should be directed to analystmediarelations@pjc.com . All other media inquiries should be directed to Pamela Steensland at pamela.k.steensland@pjc.com .

Information as of November 20, 2017 . Subject to change.

About Piper Jaffray
Piper Jaffray Companies (NYSE: PJC) is a leading investment bank and asset management firm. Securities brokerage and investment banking services are offered in the U.S. through Piper Jaffray & Co. , member SIPC and FINRA; in Europe through Piper Jaffray Ltd. , authorized and regulated by the U.K. Financial Conduct Authority ; and in Hong Kong through Piper Jaffray Hong Kong Limited , authorized and regulated by the Securities and Futures Commission . Asset management products and services are offered through five separate investment advisory affiliates―U.S. Securities and Exchange Commission ( SEC ) registered Advisory Research, Inc. , Piper Jaffray Investment Management LLC , PJC Capital Partners LLC and Piper Jaffray & Co. , and Guernsey-based Parallel General Partners Limited , authorized and regulated by the Guernsey Financial Services Commission .

© 2017 Piper Jaffray Companies . 800 Nicollet Mall, Suite 1000, Minneapolis, Minnesota 55402-7036

Follow Piper Jaffray : LinkedIn | Facebook | Twitter

View source version on businesswire.com: http://www.businesswire.com/news/home/20171122005594/en/

Source: Piper Jaffray Companies

Piper Jaffray Companies
Pamela Steensland, 612-303-8185
pamela.k.steensland@pjc.com